Pharmacokinetics of a single intramuscular injection of ceftiofur crystalline-free acid in American black ducks (Anas rubripes)

Katharine L. Hope Department of Animal Health, Smithsonian National Zoological Park, 3001 Connecticut Ave NW, Washington, DC 20008.

Search for other papers by Katharine L. Hope in
Current site
Google Scholar
PubMed
Close
 DVM
,
Lisa A. Tell Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by Lisa A. Tell in
Current site
Google Scholar
PubMed
Close
 DVM
,
Barbara A. Byrne Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by Barbara A. Byrne in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Suzan Murray Department of Animal Health, Smithsonian National Zoological Park, 3001 Connecticut Ave NW, Washington, DC 20008.

Search for other papers by Suzan Murray in
Current site
Google Scholar
PubMed
Close
 DVM
,
Scott E. Wetzlich Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by Scott E. Wetzlich in
Current site
Google Scholar
PubMed
Close
 BS
,
Lisa H. Ware Smithsonian Conservation Biology Institute, Smithsonian National Zoological Park, 1500 Remount Rd, Front Royal, VA 22630.

Search for other papers by Lisa H. Ware in
Current site
Google Scholar
PubMed
Close
,
Warren Lynch Smithsonian Conservation Biology Institute, Smithsonian National Zoological Park, 1500 Remount Rd, Front Royal, VA 22630.

Search for other papers by Warren Lynch in
Current site
Google Scholar
PubMed
Close
 BA
,
Luis R. Padilla Smithsonian Conservation Biology Institute, Smithsonian National Zoological Park, 1500 Remount Rd, Front Royal, VA 22630.

Search for other papers by Luis R. Padilla in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Nancy C. Boedeker Department of Animal Health, Smithsonian National Zoological Park, 3001 Connecticut Ave NW, Washington, DC 20008.

Search for other papers by Nancy C. Boedeker in
Current site
Google Scholar
PubMed
Close
 DVM

Abstract

Objective—To determine the pharmacokinetic properties of 1 IM injection of ceftiofur crystalline-free acid (CCFA) in American black ducks (Anas rubripes).

Animals—20 adult American black ducks (6 in a preliminary experiment and 14 in a primary experiment).

Procedures—Dose and route of administration of CCFA for the primary experiment were determined in a preliminary experiment. In the primary experiment, CCFA (10 mg/kg, IM) was administered to ducks. Ducks were allocated into 2 groups, and blood samples were obtained 0.25, 0.5, 1, 2, 4, 8, 12, 48, 96, 144, 192, and 240 hours or 0.25, 0.5, 1, 2, 4, 8, 24, 72, 120, 168, and 216 hours after administration of CCFA. Plasma concentrations of ceftiofur free acid equivalents (CFAEs) were determined by use of high-performance liquid chromatography. Data were evaluated by use of a naive pooled-data approach.

Results—The area under the plasma concentration versus time curve from 0 hours to infinity was 783 h•μg/mL, maximum plasma concentration observed was 13.1 μg/mL, time to maximum plasma concentration observed was 24 hours, terminal phase half-life was 32.0 hours, time that concentrations of CFAEs were higher than the minimum inhibitory concentration (1.0 μg/mL) for many pathogens of birds was 123 hours, and time that concentrations of CFAEs were higher than the target plasma concentration (4.0 μg/mL) was 73.3 hours.

Conclusions and Clinical Relevance—On the basis of the time that CFAE concentrations were higher than the target plasma concentration, a dosing interval of 3 days can be recommended for future multidose CCFA studies.

Abstract

Objective—To determine the pharmacokinetic properties of 1 IM injection of ceftiofur crystalline-free acid (CCFA) in American black ducks (Anas rubripes).

Animals—20 adult American black ducks (6 in a preliminary experiment and 14 in a primary experiment).

Procedures—Dose and route of administration of CCFA for the primary experiment were determined in a preliminary experiment. In the primary experiment, CCFA (10 mg/kg, IM) was administered to ducks. Ducks were allocated into 2 groups, and blood samples were obtained 0.25, 0.5, 1, 2, 4, 8, 12, 48, 96, 144, 192, and 240 hours or 0.25, 0.5, 1, 2, 4, 8, 24, 72, 120, 168, and 216 hours after administration of CCFA. Plasma concentrations of ceftiofur free acid equivalents (CFAEs) were determined by use of high-performance liquid chromatography. Data were evaluated by use of a naive pooled-data approach.

Results—The area under the plasma concentration versus time curve from 0 hours to infinity was 783 h•μg/mL, maximum plasma concentration observed was 13.1 μg/mL, time to maximum plasma concentration observed was 24 hours, terminal phase half-life was 32.0 hours, time that concentrations of CFAEs were higher than the minimum inhibitory concentration (1.0 μg/mL) for many pathogens of birds was 123 hours, and time that concentrations of CFAEs were higher than the target plasma concentration (4.0 μg/mL) was 73.3 hours.

Conclusions and Clinical Relevance—On the basis of the time that CFAE concentrations were higher than the target plasma concentration, a dosing interval of 3 days can be recommended for future multidose CCFA studies.

All Time Past Year Past 30 Days
Abstract Views 135 0 0
Full Text Views 979 636 92
PDF Downloads 386 166 11
Advertisement